Fedha

Hisa unazofuatilia
1093:HKG
CSPC Pharmaceutical Group Ltd
HK$ 8.88
+0.17%
(+0.015) Siku 1
16 Okt, 16:08:14 GMT +8  ·   HKD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 1093...
Fungua
HK$ 9.09
Juu
HK$ 9.19
Chini
HK$ 8.77
Mtaji wa soko
102.26B
Wastani wa kiasi cha mauzo
76.68M
Kiasi cha mauzo ya hisa
72.90M
Gawio
3.72%
Mgawo wa faida wa kila robo mwaka
HK$ 0.08
Tarehe ya kutojumuisha gawio
20 Okt 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
11.64
Juu kwa wiki 52
HK$ 10.96
Chini kwa wiki 52
HK$ 6.53
EPS
HK$ 0.76
Hisa za wawekezaji
11.52B
Idadi ya wafanyakazi
elfu 19
Fungua
HK$ 9.09
Juu
HK$ 9.19
Chini
HK$ 8.77
Mtaji wa soko
102.26B
Wastani wa kiasi cha mauzo
76.68M
Kiasi cha mauzo ya hisa
72.90M
Gawio
3.72%
Mgawo wa faida wa kila robo mwaka
HK$ 0.08
Tarehe ya kutojumuisha gawio
20 Okt 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
11.64
Juu kwa wiki 52
HK$ 10.96
Chini kwa wiki 52
HK$ 6.53
EPS
HK$ 0.76
Hisa za wawekezaji
11.52B
Idadi ya wafanyakazi
elfu 19
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia
Kuhusu CSPC Pharmaceutical Group Ltd
Afisa Mkuu Mtendaji (CEO)Zhang Cuilong
Wafanyakazielfu 18.6
Lilianzishwa1992
Makao makuu-
Sekta-
Ripoti ya mwisho
20 Ago 2026
Kipindi cha Kifedha
Robo2 2026
- / -
Mapato dhidi ya makadirio (HKD)
14.13B / 10.11B
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika HKD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika CNY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
6.62B
6.11B
6.47B
12.13B
Gharama ya bidhaa zilizouzwa
2.28B
2.11B
2.20B
2.24B
Gharama ya mapato
2.28B
2.11B
2.20B
2.24B
Gharama za utafiti na maendeleo
1.50B
1.62B
1.40B
1.63B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.97B
1.87B
1.89B
1.89B
Gharama ya uendeshaji
3.47B
3.49B
3.29B
3.51B
Jumla ya gharama za uendeshaji
5.75B
5.60B
5.49B
5.75B
Mapato ya uendeshaji
869.63M
514.71M
973.82M
6.38B
Mapato mengine yasiyo ya uendeshaji
645.14M
-470.42M
181.80M
11.92M
EBT ikijumuisha vipengee visivyo vya kawaida
1.18B
505.59M
1.13B
6.40B
EBT bila kujumuisha vipengee visivyo vya kawaida
1.37B
186.56M
1.13B
6.35B
Gharama ya kodi ya mapato
222.47M
165.64M
243.25M
825.70M
Kiwango cha kodi kinachotumika
18.78%
32.76%
21.46%
12.91%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
963.54M
370.72M
859.79M
5.23B
Kiwango cha faida halisi
14.56%
6.06%
13.30%
43.16%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
-
195.87M
-
91.68M
Gharama ya riba
-104.94M
-6.76M
-11.01M
-2.30M
Jumla ya gharama halisi za riba
-104.94M
189.12M
-11.01M
89.37M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
1.14B
802.06M
1.26B
6.67B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google